Year of Publication
2018
College
Public Health
Date Available
5-1-2018
Degree Name
Master of Public Health (M.P.H.)
Committee Member
Terry Bunn, PhD
Advisor
Sarah Wackerbarth, PhD
Committee Member
Tisha Johnson, MD, MPH
Co-Director of Graduate Studies
Moaz Abdelwadoud, MD, DrPH, MPH
Abstract
Gabapentin is an anticonvulsant and nerve pain medication with a variety of offlabel indications. There is at least some evidence that physicians have prescribed gabapentin to successfully treat several off-label conditions including alcohol dependence and withdrawal, brachioradial pruritus, chronic, refractory cough, diabetic neuropathy, fibromyalgia, hiccups (singultus), hot flashes, insomnia, neuropathic pain, adjunct therapy for postoperative pain, restless legs syndrome (RLS), anxiety disorders, and uremic pruritus.
An observational cross-sectional study was used to determine the various reallife off-label uses of gabapentin and physicians’ perspectives with regard to particular advantages over other drugs and interventions, via an online survey. In addition, a secondary objective was to determine physicians’ perspectives regarding whether gabapentin is being misused. The most common off-label indications for prescribing gabapentin for Family Medicine and most other physicians surveyed were neuropathic pain, diabetic neuropathy, and fibromyalgia. Psychiatrists most commonly prescribed gabapentin for anxiety disorders and insomnia. With respect to misuse and overdose, six Emergency Medicine physicians felt that gabapentin was not leading to increased overdoses and/or intoxications while three felt that it was.
Recommended Citation
Buzsaki, Lili, "Gabapentin Prescribing Practices Among Physicians: Clinical Indications and Reasoning" (2018). Theses and Dissertations--Public Health (M.P.H. & Dr.P.H.). 190.
https://uknowledge.uky.edu/cph_etds/190